| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/24/2013 | CA2464199C A composition and method to alter lean body mass and bone properties in a subject |
| 12/24/2013 | CA2397199C Nogo receptor-mediated blockade of axonal growth |
| 12/24/2013 | CA2375104C Prevention and treatment of amyloidogenic disease |
| 12/24/2013 | CA2368948C Envelope gene-deficient virus vector of paramyxoviridae |
| 12/24/2013 | CA2302484C Cultures of human cns neural stem cells |
| 12/19/2013 | WO2013188876A2 Methods for modulating kallikrein (klkb1) expression |
| 12/19/2013 | WO2013188873A1 Compositions and methods for enhancing immune responses |
| 12/19/2013 | WO2013188824A2 Hexim-1 as a target of leptin signaling to regulate obesity and diabetes |
| 12/19/2013 | WO2013188787A1 INHIBITORS OF MICRORNAs THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF |
| 12/19/2013 | WO2013188666A1 Beta-2 chimaerin as a mediator of axonal and synaptic pruning |
| 12/19/2013 | WO2013188316A1 Optical regulation of gene expression in the retina |
| 12/19/2013 | WO2013186398A1 Tfeb for use in treating obesity or metabolic syndrome |
| 12/19/2013 | WO2013162350A3 Circular antiviral rna |
| 12/19/2013 | WO2013151736A3 In vivo production of proteins |
| 12/19/2013 | WO2013151668A3 Modified polynucleotides for the production of secreted proteins |
| 12/19/2013 | US20130337549 Materials and methods for nerve grafting |
| 12/19/2013 | US20130337543 Aav4 vector and uses thereof |
| 12/19/2013 | US20130337067 Non-viral nanoparticle-based delivery system |
| 12/18/2013 | EP2674440A2 Multivalent immunoglobulin-based bioactive assemblies |
| 12/18/2013 | EP2673002A2 Methods of treating alzheimer's disease with apo a-1 milano |
| 12/18/2013 | EP2673001A2 Nts-polyplex nanoparticles system for gene therapy of cancer |
| 12/18/2013 | EP1932541B1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent |
| 12/18/2013 | EP1606407B1 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 12/18/2013 | EP1507791B1 Antisense antiviral agent and method for treating ssrna viral infection |
| 12/18/2013 | CN103459599A Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG |
| 12/18/2013 | CN103458931A Nts-polyplex nanoparticles system for gene therapy of cancer |
| 12/18/2013 | CN103451231A Schistosomiasis japonica vaccine establishment and application using mankind replication-deficient recombinant adenovirus as carrier |
| 12/18/2013 | CN103451199A HIV-1 (human immunodeficiency virus-1) multi-epitope DNA (deoxyribonucleic acid) vaccine |
| 12/18/2013 | CN103451186A Interference fragment of colipase-like 2 (Clpsl2) gene and application of interference fragment |
| 12/18/2013 | CN103451172A Modified factor vii polypeptides and uses thereof |
| 12/18/2013 | CN103450360A Antibodies to cd40 |
| 12/18/2013 | CN103450355A Recombined bovine alpha interferon and application thereof |
| 12/18/2013 | CN103450347A Polypeptide and gene vaccine used for treating alzheimer disease |
| 12/18/2013 | CN103446593A Application of human miR-148a in preparation of drug for promoting adipocyte differentiation |
| 12/18/2013 | CN103446592A Application of human miR-1908 in preparation of drug for promoting adipose cell proliferation |
| 12/18/2013 | CN103446591A Adenovirus vectors having anti-inflammatory action and based on inhibition of vascular endothelial cell inflammation |
| 12/18/2013 | CN103446585A Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid and lung cancer and therapeutic use of ProNGF |
| 12/18/2013 | CN103446584A Method of treating hemolytic disease |
| 12/18/2013 | CN102614529B Drug delivery system for treating nasopharyngeal carcinoma (NPC) and construction method and application method thereof |
| 12/18/2013 | CN102526718B Recombinant H5N1 (Hemagglutinin 5 Neuraminidase 1) avian influenza virus cell vaccine and application thereof |
| 12/18/2013 | CN102228698B HPV58 (Human Papilloma Virus) type therapeutic composite genetic vaccine and construction method thereof |
| 12/18/2013 | CN102212556B Recombinant adeno-associated virus vector of tumour-targeted double genes |
| 12/18/2013 | CN102140441B Bird flu vaccine by using attenuated vaccinia Tian Tan as vector |
| 12/18/2013 | CN101448527B Cell-matrix microspheres, methods for preparation and applications |
| 12/17/2013 | US8609830 Methods and compositions for RNA interference |
| 12/17/2013 | US8609624 Methods and compositions for the inhibition of Stat5 in prostate cancer cells |
| 12/17/2013 | US8609395 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
| 12/17/2013 | US8609109 HIV vaccine formulations |
| 12/17/2013 | US8609108 Gamma-glutamyl transpeptidase attenuated Francisella |
| 12/17/2013 | US8609103 Megalin-based delivery of therapeutic compounds to the brain and other tissues |
| 12/17/2013 | CA2563538C Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations |
| 12/17/2013 | CA2536254C Recombinant double-stranded rna phages and uses thereof |
| 12/17/2013 | CA2504401C Drug delivery systems for the prevention of neointimal hyperlasia |
| 12/17/2013 | CA2500577C The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine |
| 12/17/2013 | CA2478855C Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 12/17/2013 | CA2427310C Imaging, diagnosis and treatment of angiogenesis-related diseases comprising ecsm4 |
| 12/12/2013 | WO2013185069A1 Pulmonary delivery of mrna to non-lung target cells |
| 12/12/2013 | WO2013185032A1 Nanotherapeutics for drug targeting |
| 12/12/2013 | WO2013184197A1 Controlled gene expression methods |
| 12/12/2013 | WO2013183656A1 Conjugate of g-protein coupled receptor binding ligand and nucleic acid molecule |
| 12/12/2013 | WO2013158744A3 Nanoparticles of cerium and amino acids |
| 12/12/2013 | WO2013143683A8 Rna formulation for immunotherapy |
| 12/12/2013 | WO2013131644A8 A novel drug delivery system based on jcv-vlp |
| 12/12/2013 | US20130331547 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
| 12/12/2013 | US20130331435 Antisense modulation of kinesin-like 1 expression |
| 12/12/2013 | US20130330821 Neural progenitor cells derived from embryonic stem cells |
| 12/12/2013 | US20130330315 Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase |
| 12/12/2013 | CA2876139A1 Nanotherapeutics for drug targeting |
| 12/12/2013 | CA2875945A1 Controlled gene expression methods |
| 12/11/2013 | EP2670772A1 Antagonists of grasp55 for use as a medicament |
| 12/11/2013 | EP2670443A2 Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof |
| 12/11/2013 | EP2670442A2 Methods and compositions for increasing sialic acid production and treating sialic related disease conditions |
| 12/11/2013 | EP2670422A1 Antagonism of the vip signaling pathway |
| 12/11/2013 | EP2670421A2 Use of icam-1 for prevention or treatment of neurological diseases |
| 12/11/2013 | CN103436555A Construction method and application of adipose-derived mesenchymal stem cells (AMSC) carrying miR-122 |
| 12/11/2013 | CN103435815A Method for applying functionalized poly(amidoamine) dendrimer and nanometer compound thereof in gene transfection |
| 12/11/2013 | CN103435814A Non-viral genetic vector material and preparation method and application thereof, and brain-targeted gene transfer system and preparation method and application thereof |
| 12/11/2013 | CN103435690A DNA (deoxyribonucleic acid) vaccine of HCV (hepatitis C virus) and preparation method thereof |
| 12/11/2013 | CN103435683A SPARC-derived cancer rejection antigen peptide and pharmaceutical comprising the same |
| 12/11/2013 | CN103432595A Application of human miR-26b in preparation of drugs for inhibiting fat cell proliferation |
| 12/11/2013 | CN103432594A Application of medicine or product prepared by aptamer and used for treating multiple myeloma |
| 12/11/2013 | CN103432593A Medicine composition for preventing or treating esophageal carcinoma |
| 12/11/2013 | CN103432592A Treatment of intestinal conditions by a compound which causes RNA interference |
| 12/11/2013 | CN103432574A Application of peroxidase to preparation of drug for preventing and treating cerebrovascular diseases |
| 12/11/2013 | CN103432079A Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1 |
| 12/11/2013 | CN101914161B Fusion protein HGF alpha-Fc for restraining tumor growth and application thereof |
| 12/11/2013 | CN101869716B System for monitoring bacterial tumor treatment |
| 12/10/2013 | US8604184 Chemically programmable immunity |
| 12/10/2013 | US8604176 Protein-responsive RNA control devices and uses thereof |
| 12/10/2013 | US8603997 siRNA that inhibits WT1 gene expression and uses thereof |
| 12/10/2013 | US8603994 Transcriptional repression leading to Parkinson's disease |
| 12/10/2013 | US8603993 Compositions and methods modulating MG29 for the treatment of diabetes |
| 12/10/2013 | US8603992 Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use |
| 12/10/2013 | US8603810 T-cell having a T-cell receptor that recognizes epitope HBC18-27 of hepatitis B viral core antigen |
| 12/10/2013 | US8603778 Anti-TNF antibodies, compositions, methods and uses |
| 12/10/2013 | US8603512 Methods for treating an injured nerve pathway |
| 12/10/2013 | US8603462 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 12/10/2013 | US8603459 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 12/10/2013 | US8603458 Genetic adjuvants for immunotherapy |
| 12/10/2013 | US8603457 Nonsense suppression and genetic codon alteration by targeted modification |